• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Flatiron Health, NRG Oncology to Streamline Cancer Clinical Trials with EHR-to-EDC

by Jasmine Pennic 03/19/2025 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know: 

– Flatiron Health, a healthtech company focused on revolutionizing clinical research through technology integration, has announced a collaboration with NRG Oncology, a clinical research consortium within the National Cancer Institute’s (NCI) National Clinical Trials Network (NCTN). 

– The partnership aims to deploy Flatiron’s Clinical Pipe™ in a multicenter NRG clinical trial, streamlining data entry and accelerating study timelines.

Supporting NCI-Sponsored Trials w/ NRG Oncology

Flatiron Clinical Pipe™, a cutting-edge electronic health record (EHR) to electronic data capture (EDC) connector, is designed to significantly improve the efficiency and reduce the time and effort required for clinical study data entry. By automating the transfer of data from EHRs to EDC systems, the technology minimizes manual data entry, a known burden for clinical trial site teams.

This collaboration marks a significant expansion of Flatiron Clinical Pipe™ use cases, now extending to NCTN-sponsored studies. By leveraging Flatiron’s EHR-to-EDC technology, NRG Oncology seeks to alleviate the administrative burden on its network of over 1,300 research sites worldwide, streamline data management, and accelerate the pace of clinical trials.

In conjunction with the trial deployment, NRG and Flatiron will conduct a correlative study to rigorously assess the efficiency of Flatiron Clinical Pipe™ compared to traditional data entry methods. This study will provide valuable insights into the real-world impact of the technology on clinical trial workflows.

Flatiron Clinical Pipe Research/Outcomes

Previous research published in the journal ESMO Real World Data and Digital Oncology has demonstrated the significant time-saving potential of Flatiron Clinical Pipe™. The study revealed that teams using the technology were able to accurately transfer thousands of data points, representing the completion of hundreds of case report forms (CRFs), with an average completion time of just 37 seconds per CRF. This represents a substantial reduction in data entry time over the course of a clinical trial.

“We are very excited about the rich potential of this collaboration with our partners at Flatiron, a leader in healthcare systems technology. Enhancing clinical trial efficiency with Clinical Pipe, and other emerging technologies, holds the promise of delivering NRG clinical trial results to our patients with greater accuracy and speed, helping us deliver on the promise of less suffering from cancer through operational advances.” Alexandra Thomas MD, FACP, Vice Chair NRG Protocol Operation Management

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Clinical Trails, Flatiron Health, Oncology, Oncology Platform

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Kinetik CEO Sufian Chowdhury on Fighting NEMT Fraud & Waste

Most-Read

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

WeightWatchers Files for Bankruptcy to Eliminate $1.15B in Debt

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

KLAS: Epic Dominates 2024 EHR Market Share Amid Focus on Vendor Partnership; Oracle Health Sees Losses Despite Tech Advances

'Cranky Index' Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

‘Cranky Index’ Reveals EHR Alert Frustration Peaks Midweek, Highest Among Admin Staff

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Madison Dearborn Partners to Acquire Significant Stake in NextGen Healthcare

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Wandercraft Begins Clinical Trials for Physical AI-Powered Personal Exoskeleton

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |